News

Thomas Maimone of the Department of Chemistry has been selected by the Rose Hills Innovator Program for his innovative research entitled: Synthetic Antibiotic Drug Discovery Platforms Inspired by Natural Products.Read more about Maimone selected by Rose Hills Innovator Program

A team of Berkeley undergrads, including two from CBE, have won the Tech Innovation design challenge in the 2017 L’Oréal USA Brandstorm.Read more about CBE students win L’Oréal competition

Read more about Yaghi wins Royal Society of Chemistry award

Alexandra East-Seletsky, Jennifer Doudna, and fellow researchers have described 10 new CRISPR enzymes that, once activated, behave like Pac-Man to chew up RNA in a way that could be used as sensitive detectors of infectious viruses.Read more about Pac-Man-like CRISPR enzymes have potential for disease diagnostics

Part of the 2017 Berkeley Summer Reading List, A Crack in Creation discusses the origin and impact of the CRISPR-Cas9 gene-editing technology co-invented by...Read more about Summer Reading List: A Crack in Creation

Chandler (r.) with fellow chemistry professor (and former student) Phillip Geissler at the opening of the Pitzer Center expansion in Gilman Hall, November 2016. Photo by Michael Barnes.

David Chandler, pillar of the physical chemistry scientific community and Professor...Read more about David Chandler, pillar of physical chemistry, dies at the age of 72

CBE alum Bernardo Gouveia is among the 30 chosen recipients to receive the 2017 Paul and Daisy Soros Fellowships for New Americans.Read more about Berkeley student, alums awarded ‘New Americans’ fellowships

The 2017 Japan Prize in the life sciences was presented to the two inventors of the CRISPR-Cas9 gene-editing tool that is revolutionizing biological...Read more about Japan Prize presented to CRISPR gene-editing inventors in Tokyo ceremony

UC Berkeley biochemist discusses how CRISPR could affect chemistry in areas including drug discovery and agriculture.Read more about CRISPR pioneer Jennifer Doudna shares her outlook for the groundbreaking gene-editing tool